Hölzl, D.; Hutarew, G.; Zellinger, B.; Alinger-Scharinger, B.; Schlicker, H.U.; Schwartz, C.; Sotlar, K.; Kraus, T.F.J.
EGFR Amplification Is a Phenomenon of IDH Wildtype and TERT Mutated High-Grade Glioma: An Integrated Analysis Using Fluorescence In Situ Hybridization and DNA Methylome Profiling. Biomedicines 2022, 10, 794.
https://doi.org/10.3390/biomedicines10040794
AMA Style
Hölzl D, Hutarew G, Zellinger B, Alinger-Scharinger B, Schlicker HU, Schwartz C, Sotlar K, Kraus TFJ.
EGFR Amplification Is a Phenomenon of IDH Wildtype and TERT Mutated High-Grade Glioma: An Integrated Analysis Using Fluorescence In Situ Hybridization and DNA Methylome Profiling. Biomedicines. 2022; 10(4):794.
https://doi.org/10.3390/biomedicines10040794
Chicago/Turabian Style
Hölzl, Dorothee, Georg Hutarew, Barbara Zellinger, Beate Alinger-Scharinger, Hans U. Schlicker, Christoph Schwartz, Karl Sotlar, and Theo F. J. Kraus.
2022. "EGFR Amplification Is a Phenomenon of IDH Wildtype and TERT Mutated High-Grade Glioma: An Integrated Analysis Using Fluorescence In Situ Hybridization and DNA Methylome Profiling" Biomedicines 10, no. 4: 794.
https://doi.org/10.3390/biomedicines10040794
APA Style
Hölzl, D., Hutarew, G., Zellinger, B., Alinger-Scharinger, B., Schlicker, H. U., Schwartz, C., Sotlar, K., & Kraus, T. F. J.
(2022). EGFR Amplification Is a Phenomenon of IDH Wildtype and TERT Mutated High-Grade Glioma: An Integrated Analysis Using Fluorescence In Situ Hybridization and DNA Methylome Profiling. Biomedicines, 10(4), 794.
https://doi.org/10.3390/biomedicines10040794
